This video is currently visible only to AAPM Members, Affiliates and Developing Country Educational Associates. Embargo periods are typically one year from the date the presentation was first published.
A DNA Repair Inhibitor Targeting ATR Modulates Immune Responses to Radiotherapy Scott Bright UT MD Anderson Cancer Center SJBright@mdanderson.org
Features Of TOPAS-NBio – Release 1.0 - Jan Schuemann, PhD Physics Division, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
Graph includes 5 member loads and excludes non-members. Include? A load is defined as someone coming to this page, not necesarily that they pressed play, or watched the entire presentation.